Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664) |
---|
05/21/2004 | WO2004041266A1 Receptor function controlling agent |
05/21/2004 | WO2003084929A8 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa |
05/21/2004 | CA2505322A1 Receptor function regulator |
05/20/2004 | US20040097755 Ionic liquids and their use as solvents |
05/20/2004 | US20040097754 Three-dimensional catalyst support structure carrying reducible metal oxide with a Group 8 promoter metal; preparing a carboxylic acid or nitrile by adding an additional catalyst and oxygen source or ammonia |
05/20/2004 | US20040097602 Gelling agents or thickeners |
05/20/2004 | US20040097593 Compounds for treatment of inflammation, diabetes and related disorders |
05/20/2004 | US20040097589 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
05/20/2004 | US20040097585 4-(2,6-difluorophenyl)-4-oxobutyric acid and derivatives; milder side effects; insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis, arteriosclerosis |
05/20/2004 | US20040097500 Compounds and compositions for delivering active agents |
05/19/2004 | EP1420006A1 Alkylenebisnaphtol derivatives and charge control agent comprising the same |
05/19/2004 | EP1419138A1 N- (1-dimethylaminocycloalkyl)methyl]benzamide derivatives |
05/19/2004 | EP1095932B1 Phenoxyacetic acid derivatives and medicinal compositions containing the same |
05/19/2004 | EP1047664B1 Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
05/19/2004 | DE60003103T2 Substituierte dimere Verbindungen Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen Substituted dimeric compounds process for their preparation and their pharmaceutical compositions |
05/19/2004 | DE10250743A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
05/13/2004 | WO2004039865A1 Polyamine derivatives, a process to make them, and their use |
05/13/2004 | WO2004039764A1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
05/13/2004 | WO2004039762A1 Phenethanolamine derivatives for the treatment of respiratory diseases |
05/13/2004 | WO2004039753A2 Phenyl compounds |
05/13/2004 | WO2004026305A9 Diaryl ethers as opioid receptor antagonist |
05/13/2004 | US20040092598 Antiproliferative agnets; anticancer agents; skin disorders |
05/13/2004 | US20040092594 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
05/13/2004 | US20040092518 Compounds for the treatment of metabolic disorders |
05/13/2004 | US20040092516 Insulin resistance; antidiabetic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders |
05/13/2004 | US20040092015 Coupling; binding aldehyde compound forming hydrazone compound; lipophilic vector |
05/13/2004 | CA2503735A1 Polyamine derivatives, a process to make them, and their use |
05/12/2004 | EP1163208B1 Caspase inhibitors and uses thereof |
05/12/2004 | EP0915833B1 Fluorination of ketoamides |
05/12/2004 | EP0912498B1 4(4-oxocyclohexyl) benzamides as intermediate products for medicaments |
05/12/2004 | CN1495157A Preparation method of cyanophthaofluoroaniline |
05/11/2004 | US6734203 Fused imidazolium derivatives |
05/06/2004 | WO2004037751A2 Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof |
05/06/2004 | WO2004037750A2 Short-acting sedative hypnotic agents for anesthesia and sedation |
05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
05/06/2004 | US20040087794 Alpha bromination of p-(3-(dimethylaminocarbonyl)propionyl)-toluene |
05/06/2004 | US20040087655 6-Substituted indanoyl amino acid conjugates as mimics to the biological activity of coronatine |
05/06/2004 | US20040087650 Inhibitors of IMPDH enzyme |
05/06/2004 | US20040087590 Novel biphenyl and biphenyl-like cannabinoids |
05/06/2004 | US20040087582 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents |
05/06/2004 | US20040087491 Electrophilic ketones for the treatment of herpesvirus infections |
05/06/2004 | US20040087453 Photo-labile pro-fragrance conjugates |
05/06/2004 | US20040086462 Radio-opaque polymer biomaterials |
05/06/2004 | US20040086461 Radio-opaque polymer biomaterials |
05/06/2004 | US20040086458 Radio-opaque polymer biomaterials |
05/06/2004 | EP1414788A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
05/06/2004 | EP1414787A1 New derivatives of substituted anilines with herbicidal activity |
05/06/2004 | EP1414786A1 Process for obtaining n-monosubstituted amides |
05/06/2004 | EP1414784A2 Amphiphilic star-like macromolecules for drug delivery |
05/06/2004 | EP1414780A1 Interfacial method of preparing ester-substituted diaryl carbonates |
05/06/2004 | CA2497060A1 Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof |
05/05/2004 | CN1494527A Or tho-substituted and meta-substituted bis-aryl compounds, method for production thereof, their use as medicament, and pharmaceutical preparations containing there compounds |
05/05/2004 | CN1494425A Carboxamide derivatives as therapeutic agents |
05/05/2004 | CN1494420A Compounds and compositions for delivering active agents |
04/29/2004 | WO2004035736A2 Halogenated selective androgen receptor modulators and methods of use thereof |
04/29/2004 | WO2004035525A1 Inhibitors of histone deacetylase |
04/29/2004 | WO2003009807A3 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
04/29/2004 | US20040082664 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition |
04/29/2004 | US20040082625 Osteoporosis, bone disorders |
04/29/2004 | CA2588083A1 Selective androgen receptor modulators and methods of use thereof |
04/29/2004 | CA2502355A1 Halogenated selective androgen receptor modulators and methods of use thereof |
04/29/2004 | CA2501265A1 Inhibitors of histone deacetylase |
04/28/2004 | EP1412322A2 Protected 3.5-dihydroxy-2.2-dimethyl-valeroamides for the synthesis of epothilone and derivatives and method for the production and use thereof |
04/28/2004 | EP1412320A1 Linked cyclitols and their polysulfated derivatives |
04/28/2004 | EP1200384B1 2-alkyl-5-halogen-pent-4-ene carboxylic acids and their production |
04/28/2004 | EP0585366B1 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
04/28/2004 | CN1492852A N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD |
04/28/2004 | CN1492763A Compositions for delivering bisphosphonates |
04/28/2004 | CN1147483C Adamantane derivatives |
04/27/2004 | US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
04/27/2004 | US6727237 Alkylating 5-nitroindole with 6-bromohexyl acetate to form a 6-(N-(5-nitroindolyl)) hexyl acetate, hydrolyzing to form alcohol of above ester, estrifying with nicotinic acid, and methylating the intermediate |
04/22/2004 | WO2004033414A1 Mu opioid receptor ligands: methods of use and synthesis |
04/22/2004 | WO2003041728A9 Novel phenyl-propargylether derivatives |
04/22/2004 | US20040077896 Compounds for the treatment of metabolic disorders |
04/22/2004 | US20040077728 Retiferol derivatives and their use in the treatment of skin diseases or conditions associated with photodamage |
04/22/2004 | US20040077694 Malonamic acids and derivatives thereof as thyroid receptor ligands |
04/22/2004 | US20040077628 Melanin-concentrating hormone antagonist |
04/21/2004 | EP1409563A1 Photoactive materials |
04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
04/21/2004 | EP1154987B1 Phenylalaninol derivatives |
04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
04/21/2004 | CN1146542C Benzamide derivatives and their use as cytokine inhibitors |
04/21/2004 | CN1146536C Cycloethylene derivatives |
04/20/2004 | US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
04/20/2004 | US6723743 Treating patient suffering from rheumatoid arthritis, psoriasis, bronchial asthma, alzheimer's disease, myocardial infarction or atherosclerosis |
04/15/2004 | WO2004031129A2 Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
04/15/2004 | WO2004031128A1 Improved method for the production of n-substituted amides from nitriles |
04/15/2004 | WO2004031118A1 Lpa receptor antagonists |
04/15/2004 | WO2004031107A1 Method for the production of at least one partial propylene oxidation and/or ammoxidation product |
04/15/2004 | WO2004031106A1 Method for the production of at least one partial propylene oxidation and/or ammoxidation product |
04/15/2004 | WO2003083063A3 Common ligand mimics: naphtoates |
04/15/2004 | US20040072880 Cycloalkyl inhibitors of potassium channel function |
04/15/2004 | US20040072878 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
04/15/2004 | US20040072868 Liver disorders; anticholesterol agents; cardiovascular disorders |
04/15/2004 | US20040072307 Processes for enhanced production of pantothenate |
04/15/2004 | US20040071187 Compound having at least two aromatic rings substituted with at least one carboxy group |
04/15/2004 | CA2500935A1 Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
04/14/2004 | EP1406860A1 Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives via 6-cyano syn 3,5-dihydroxy hexanoic acid derivatives |